K-numberK242931
Device nameHFT750U
ApplicantMekics Co., Ltd.
Product codeMNT
Device classClass II
Decision dateMay 15, 2025
DecisionSubstantially Equivalent
Regulation868.5895
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The HFT750U is a continuous ventilator providing ventilation and oxygen concentration for spontaneously breathing patients who need partial support due to respiratory failure or chronic insufficiency. It delivers heated and humidified gas in high-flow, CPAP, and bilevel modes for pediatric patients ≥12.5 kg to adult patients in hospitals and hospital transport, and is not intended for life support.

Technological characteristics

The HFT750U uses a blower-driven system with proportional oxygen control, microprocessor regulation, and an integrated heated humidifier—similar to the secondary predicate (Fisher & Paykel Airvo 3 NIV). Key differences from the primary predicate (Nihon Kohden NKV-330) include the integrated humidifier versus external attachment and fewer ventilator modes with fewer measured parameters, though the technology and control strategy remain substantially similar.

Test standards cited

ISO 80601-2-12 Ed.3, ISO 80601-2-55 Ed.2, ISO 80601-2-61 Ed.2, ISO 80601-2-74 Ed.2, ISO 80601-2-90 Ed.1; IEC 60601-1 Ed.3.2, IEC 60601-1-2 Ed.4.1, IEC 60601-1-6 Ed.3.1, IEC 60601-1-8; IEC 62133-2 Ed.1 and IEC 62366-1 Ed.1 for electrical safety, EMC, and biocompatibility.

Substantial equivalence argument

The HFT750U is substantially equivalent because it shares the same intended use, patient population (pediatric ≥12.5 kg to adult), clinical indications, and hospital environments as the predicates. The technology is functionally identical—blower-driven positive pressure with proportional oxygen control and integrated humidification. Design differences (integrated versus external humidifier, fewer modes) do not raise new safety risks and are addressed by the secondary predicate. All measured parameters and calculated indices (S/F, ROX) are derived from existing clinical measurements and do not drive therapy control, thus raising no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →